| 张静,王羽,刘慧,戴惠珍.南京地区肿瘤治疗辅助药的利用分析[J].中国药事,2018,32(6):823-828 |
| 南京地区肿瘤治疗辅助药的利用分析 |
| Utilization of Antineoplastic Adjuvant Drugs in Nanjing |
| 投稿时间：2017-02-22 |
| DOI：10.16153/j.1002-7777.2018.06.022 |
| 中文关键词: 肿瘤治疗辅助药 合理用药 用药金额 用药频度 日均费用 |
| 英文关键词: antineoplastic adjuvant drugs rational drug use drug consumption sum DDDs DDC |
| 基金项目: |
|
| 摘要点击次数: 1259 |
| 全文下载次数: 696 |
| 中文摘要: |
| 目的：探讨南京地区肿瘤治疗辅助药的临床使用情况。方法：采用回顾性调查方法，对南京地区医院2012-2014年肿瘤治疗辅助药的用药金额、用药频度（DDDs）、日均费用（DDC）及排序比（B/A）进行分析。结果：2012-2014年，该地区医院肿瘤治疗辅助药的用药金额呈上升趋势。用药金额排名靠前的康莱特、消癌平、康艾注射液、艾迪注射液等用药金额与用药人次同步性较差，临床使用不合理。结论：肿瘤治疗辅助药在抗肿瘤治疗中占据重要地位，应进一步规范其临床应用，提高用药安全性和经济性。 |
| 英文摘要: |
| Objective:To discuss the clinic utilization of antineoplastic adjuvant drugs in Nanjing. Methods:The drug consumption sum, defined daily doses (DDDs), defined daily consumption (DDC) and B/A of antineoplastic adjuvant drugs in hospitals in Nanjing from 2012 to 2014 were analyzed retrospectively. Results:The consumption sum of antineoplastic adjuvant drugs showed an upward trend from 2012 to 2014. The B/A of Kanglaite, Xiaoaiping, Kangai injections, as well as Aidi injections were less than 1 and the clinic utilization of those drugs was irrational. Conclusion:Antineoplastic adjuvant drugs played an important role in cancer therapy. The utilization of antineoplastic adjuvant drugs should be further standardized to improve the safety and economy in drug use. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |